- Home
- About
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Supporting Organizations
Psychotherapeutic Approaches in PTSD Treatment

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Psychotherapeutic Approaches in PTSD Treatment
Clinical guidelines recommend both pharmacologic and non-pharmacological interventions in the treatment of post-traumatic stress disorder (PTSD)1. This presentation will highlight these interventions in addition to exploring the benefits of combined pharmacological and non-pharmacologic treatments. Objectives for this webinar include: a review of PTSD diagnostic criteria; common psychotherapies utilized in PTSD; a discussion of the challenges associated with engaging patients in psychotherapy; and the benefits of combined pharmacologic and non-pharmacologic treatments.
Join us for an informative webinar moderated by Haneefa Rakeeb DNP, PMHNP-BC, RN alongside esteemed speaker Christiian Storm Credle, PsyD.
References:
- U.S. Department of Veterans Affairs. 2023. www.healthquality.va.gov/guidelines/MH/ptsd/VA-DoD-CPG-PTSD-Full-CPG.pdf

Christiian Storm Credle, PsyD (he/him/his)
Director of Behavioral Health at Mazzoni Medical Center in Philadelphia, PA

Haneefa Rakeeb, DNP, PMHNP-BC, AFN-BC
Medical Science Liaison, Otsuka Pharmaceutical Development & Commercialization, Inc.
More
Christiian Storm Credle, PsyD, is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc.
Haneefa Rakeeb, DNP, PMHNP-BC, RN is a paid employee of Otsuka Pharmaceutical Development & Commercialization, Inc.
Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
June 2024 US.CORP.X.24.00197